microdosing glp 1 agonists of GLP-1's / Wellness Services / Services Microdosing GLP-1: Should You Try

Description

The FDA has not approved compounded versions of these drugs, and such products may carry safety, quality, and effectiveness risks due to variations in formulation, incorrect ingredients, improper storage, or inaccurate dosing

While research in humans is still in the early stages, these findings point to the possibility that GLP-1-based treatments could help reduce cravings and withdrawal symptoms in individuals attempting to quit smoking

Potential Reasons to Consider Saxenda Insurance considerations: Your insurance covers Saxenda but not semaglutide Prior authorization requirements differ Step therapy requires trying Saxenda first Previous experience: Youve had success with Saxenda before You know you tolerate liraglutide well Youre continuing existing treatment Specific medical situations: Your provider has specific reasons to prefer liraglutide You have conditions that favor one medication over the other Part of a comprehensive treatment plan designed around liraglutide Personal preference: You strongly prefer daily dosing (some patients find this easier to remember) You want the FDA-approved weight loss indication specifically When Semaglutide Is Almost Always Better For most patients, semaglutide is preferable: Greater effectiveness: Nearly twice the weight loss makes a substantial difference in outcomes

Proposals should be made to the corresponding author and will be reviewed by the Birmingham Clinical Trials Unit Data Sharing Committee in discussion with the Chief Investigator